MDPI and ACS Style
Duangdara, J.; Boonsri, B.; Sayinta, A.; Supradit, K.; Thintharua, P.; Kumkate, S.; Suriyonplengsaeng, C.; Larbcharoensub, N.; Mingphruedhi, S.; Rungsakulkij, N.;
et al. CP-673451, a Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces Apoptosis in Opisthorchis viverrini-Associated Cholangiocarcinoma via Nrf2 Suppression and Enhanced ROS. Pharmaceuticals 2024, 17, 9.
https://doi.org/10.3390/ph17010009
AMA Style
Duangdara J, Boonsri B, Sayinta A, Supradit K, Thintharua P, Kumkate S, Suriyonplengsaeng C, Larbcharoensub N, Mingphruedhi S, Rungsakulkij N,
et al. CP-673451, a Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces Apoptosis in Opisthorchis viverrini-Associated Cholangiocarcinoma via Nrf2 Suppression and Enhanced ROS. Pharmaceuticals. 2024; 17(1):9.
https://doi.org/10.3390/ph17010009
Chicago/Turabian Style
Duangdara, Jinchutha, Boonyakorn Boonsri, Apinya Sayinta, Kittiya Supradit, Pakpoom Thintharua, Supeecha Kumkate, Chinnawut Suriyonplengsaeng, Noppadol Larbcharoensub, Somkit Mingphruedhi, Narongsak Rungsakulkij,
and et al. 2024. "CP-673451, a Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces Apoptosis in Opisthorchis viverrini-Associated Cholangiocarcinoma via Nrf2 Suppression and Enhanced ROS" Pharmaceuticals 17, no. 1: 9.
https://doi.org/10.3390/ph17010009